Getting a cell therapy from the research bench to patients requires leaping many hurdles. Perhaps two of the highest arise when proving the potential therapy is safe enough to begin clinical trials and then when scaling up production to meet the demand of thousands of patients. An even dozen CIRM-funded projects have made it over … Continue reading Cranking up stem cell production for when therapies are approved for widespread use